CDC Updates RSV Vaccination Recommendation for Adults
Jun 26, 2024 — Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
FDA approves Pfizer's RSV vaccine for adults at increased risk of …
Oct 22, 2024 — The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of...
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 — After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way.
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults …
Oct 22, 2024 — ABRYSVO now offers the broadest RSV vaccine indication for adults, which previously included those 60 years and older. Additionally, it remains the only RSV immunization approved for pregnant individuals at 32 through 36 weeks of gestation to protect infants from birth up to 6 months of age.
Federal Officials Revise Recommendations for R.S.V. Vaccine
Jun 26, 2024 — The Food and Drug Administration has approved three R.S.V. vaccines. Two of them, GSK’s Arexvy and Pfizer’s Abrysvo, were approved in May last year and were administered during the fall and...
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States.
RSV: What to know about the latest surge and treatments : NPR
Nov 2, 2022 — Here are answers to some of the most common questions about the RSV infection, who is most at risk and what might be causing this year's outbreak. Why might RSV be particularly bad this year?
FDA approves RSV vaccine for adults ages 60 and up - NBC News
May 3, 2023 — The Food and Drug Administration on Wednesday approved the world's first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the making....
CDC study shows effectiveness of RSV immunization for infants
Mar 7, 2024 — New data released today in CDC’s MMWR show that nirsevimab, a long-acting monoclonal antibody product, was highly effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV).
FDA advisers recommend world's first RSV vaccines, from ... - NBC News
Mar 1, 2023 — An FDA advisory committee has recommended that the agency approve two RSV vaccines for older people, one from Pfizer and another from GSK.